Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Reproterol hydrochloride [USAN]
RN: 13055-82-8
UNII: Y4I1COJ8W8
InChIKey: XSFWDHONRBZVEJ-UHFFFAOYSA-N

Classification Codes

  • Bronchodilator
  • Reproductive Effect

Molecular Formula

  • C18-H23-N5-O5.Cl-H

Molecular Weight

  • 425.8706
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Reproterol hydrochloride
  • Reproterol hydrochloride [USAN]

Synonyms

  • 1H-Purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-, monohydrochloride
  • 7-(3-((2-(3,5-Dihydroxyphenyl)-2-hydroxy-ethyl)amino)propyl)theophylline hydrochloride
  • 7-(3-((beta,3,5-Trihydroxyphenethyl)amino)propyl)theophylline monohydrochloride
  • Bronchodil
  • Bronchospasmin
  • D 1959 HCl
  • D-1959.HCl
  • EINECS 235-942-3
  • Reproterol HCl
  • Reproterol hydrochloride
  • UNII-Y4I1COJ8W8
  • W-2946M

Systematic Names

  • 1H-Purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-, monohydrochloride
  • 7-(3-((2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrochloride
  • Theophylline, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-, hydrochloride

Registry Numbers

CAS Registry Number

  • 13055-82-8

FDA UNII

  • Y4I1COJ8W8

Related Registry Number

  • 54063-54-6 (Parent)

System Generated Number

  • 0013055828

Molecular Formulas

Molecular Formula

  • C18-H23-N5-O5.Cl-H

Molecular Formula Fragments

  • C18-H23-N5-O5
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C18H23N5O5.ClH/c1-21-16-15(17(27)22(2)18(21)28)23(10-20-16)5-3-4-19-9-14(26)11-6-12(24)8-13(25)7-11;/h6-8,10,14,19,24-26H,3-5,9H2,1-2H3;1H

InChIKey

XSFWDHONRBZVEJ-UHFFFAOYSA-N

Smiles

n1(cnc2n(c(n(c(c12)=O)C)=O)C)CCCNC[C@@H](O)c1cc(cc(c1)O)O.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 160mg/kg (160mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

BEHAVIORAL: COMA

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 45, 1977.
dog LD50 oral 400mg/kg (400mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: COMA

SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 45, 1977.
mouse LD50 intravenous 148mg/kg (148mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 45, 1977.
mouse LD50 oral > 10gm/kg (10000mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 45, 1977.
rat LD50 intravenous 142mg/kg (142mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: ATAXIA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 45, 1977.
rat LD50 oral > 10gm/kg (10000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA
Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 45, 1977.